InvestSMART

Ramsay Health Care Limited (ASX: RHC) - Announcements

- Current share price for RHC : $42.420

ASX company news and announcements for Ramsay Health Care Limited (RHC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Ramsay Health Care Limited (RHC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Ramsay Health Care Limited (RHC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Ramsay Health Care Limited (RHC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9,792 Presentation to the UBS Australian Healthcare Forum 2015 11 Jun 2015 9:36AM $59.300 $42.420 fallen by 28.47%
$9,792 Change of registry address 18 May 2015 5:06PM $63.080 $42.420 fallen by 32.75%
$9,792 Ramsay Sime Darby signs conditional JV contract in China 15 May 2015 1:47PM $63.830 $42.420 fallen by 33.54%
$9,792 Presentation to 2015 Macquarie Australia Conference 6 May 2015 8:55AM $63.200 $42.420 fallen by 32.88%
$9,792 Securities Trading Policy 29 Apr 2015 11:49AM $64.480 $42.420 fallen by 34.21%
$9,792 Initial Director's Interest Notice 28 Apr 2015 4:09PM $64.680 $42.420 fallen by 34.42%
$9,792 Initial Director's Interest Notice 28 Apr 2015 4:09PM $64.680 $42.420 fallen by 34.42%
$9,792 Appointment of two new Directors 28 Apr 2015 12:40PM $64.570 $42.420 fallen by 34.30%
$9,792 New - Appx 3A.1 Notification of Distribution - RHCPA 21 Apr 2015 11:22AM $65.030 $42.420 fallen by 34.77%
$9,792 Appendix 4D Half Year Financial Report 26 Feb 2015 8:53AM $66.420 $42.420 fallen by 36.13%
$9,792 S&P DJ Indices Announces December Quarterly Rebalance 5 Dec 2014 8:24AM $55.510 $42.420 fallen by 23.58%
$9,792 Ramsay completes acquisition of controlling interest in GdS 2 Oct 2014 8:31AM $50.470 $42.420 fallen by 15.95%
$9,792 Anti trust clearence for controlling interest in GdS 25 Sep 2014 5:50PM $50.850 $42.420 fallen by 16.58%
$9,792 Financial Results Presentation by Mr Christopher Rex, CEO 28 Aug 2014 8:46AM $52.060 $42.420 fallen by 18.52%
$9,792 Appendix 4E Financial Report for the Year Ended 30 June 2014 28 Aug 2014 8:37AM $52.060 $42.420 fallen by 18.52%
$9,792 Ramsay acquires a controlling interest in GdS 11 Jun 2014 9:45AM $45.140 $42.420 fallen by 6.03%
$9,792 Exclusivity granted to acquire majority stake in GdS 12 May 2014 4:59PM $45.590 $42.420 fallen by 6.95%
$9,792 Amended Record Date for the Interim Dividend 25 Feb 2014 3:50PM $47.540 $42.420 fallen by 10.77%
$9,792 Half-Year Financial Report 25 Feb 2014 8:43AM $47.540 $42.420 fallen by 10.77%
$9,792 Ramsay Refinances 10 Dec 2013 2:28PM $39.270 $42.420 risen by 8.02%
$9,792 Ramsay Acquires Psychiatric Hospital Group in France 2 Dec 2013 8:27AM $39.150 $42.420 risen by 8.35%
$9,792 RAMSAY IN NEGOTIATIONS TO ACQUIRE HOSPITAL GROUP IN FRANCE 21 Oct 2013 2:48PM $37.150 $42.420 risen by 14.19%
$9,792 Final Dividend - Amended Timetable 29 Aug 2013 3:39PM $36.000 $42.420 risen by 17.83%
$9,792 Ramsay and Medibank Private Resolve Differences 29 Aug 2013 10:48AM $36.000 $42.420 risen by 17.83%
$9,792 Appendix 4E Preliminary Financial Report 30 June 2013 29 Aug 2013 8:39AM $36.000 $42.420 risen by 17.83%

651 - 675 of 748 results

Page 27 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.